MEDPACE HOLDINGS INC (1MEDP.MI) Fundamental Analysis & Valuation

BIT:1MEDP • US58506Q1094

Current stock price

380.6 EUR
-143.2 (-27.34%)
Last:

This 1MEDP.MI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. 1MEDP.MI Profitability Analysis

1.1 Basic Checks

  • In the past year 1MEDP was profitable.
  • In the past year 1MEDP had a positive cash flow from operations.
  • Each year in the past 5 years 1MEDP has been profitable.
  • Each year in the past 5 years 1MEDP had a positive operating cash flow.
1MEDP.MI Yearly Net Income VS EBIT VS OCF VS FCF1MEDP.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

1.2 Ratios

  • 1MEDP's Return On Assets of 24.70% is amongst the best of the industry. 1MEDP outperforms 100.00% of its industry peers.
  • 1MEDP's Return On Equity of 147.46% is amongst the best of the industry. 1MEDP outperforms 100.00% of its industry peers.
  • 1MEDP has a better Return On Invested Capital (91.45%) than 100.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for 1MEDP is significantly above the industry average of 9.34%.
  • The last Return On Invested Capital (91.45%) for 1MEDP is above the 3 year average (38.75%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 24.7%
ROE 147.46%
ROIC 91.45%
ROA(3y)18.14%
ROA(5y)15.16%
ROE(3y)54.33%
ROE(5y)40%
ROIC(3y)38.75%
ROIC(5y)29.27%
1MEDP.MI Yearly ROA, ROE, ROIC1MEDP.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • 1MEDP's Profit Margin of 18.36% is amongst the best of the industry. 1MEDP outperforms 81.82% of its industry peers.
  • 1MEDP's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 21.50%, 1MEDP belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
  • In the last couple of years the Operating Margin of 1MEDP has grown nicely.
  • Looking at the Gross Margin, with a value of 31.11%, 1MEDP is doing worse than 72.73% of the companies in the same industry.
  • 1MEDP's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 21.5%
PM (TTM) 18.36%
GM 31.11%
OM growth 3Y6.82%
OM growth 5Y7.46%
PM growth 3Y6.48%
PM growth 5Y10.5%
GM growth 3Y2.7%
GM growth 5Y1.75%
1MEDP.MI Yearly Profit, Operating, Gross Margins1MEDP.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

8

2. 1MEDP.MI Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so 1MEDP is creating value.
  • The number of shares outstanding for 1MEDP has been reduced compared to 1 year ago.
  • The number of shares outstanding for 1MEDP has been reduced compared to 5 years ago.
  • There is no outstanding debt for 1MEDP. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
1MEDP.MI Yearly Shares Outstanding1MEDP.MI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
1MEDP.MI Yearly Total Debt VS Total Assets1MEDP.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 6.54 indicates that 1MEDP is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 6.54, 1MEDP belongs to the top of the industry, outperforming 86.36% of the companies in the same industry.
  • 1MEDP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 6.54
ROIC/WACC8.31
WACC11.01%
1MEDP.MI Yearly LT Debt VS Equity VS FCF1MEDP.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M

2.3 Liquidity

  • 1MEDP has a Current Ratio of 0.57. This is a bad value and indicates that 1MEDP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • The Current ratio of 1MEDP (0.57) is worse than 90.91% of its industry peers.
  • A Quick Ratio of 0.57 indicates that 1MEDP may have some problems paying its short term obligations.
  • The Quick ratio of 1MEDP (0.57) is worse than 68.18% of its industry peers.
  • 1MEDP does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 0.57
Quick Ratio 0.57
1MEDP.MI Yearly Current Assets VS Current Liabilites1MEDP.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. 1MEDP.MI Growth Analysis

3.1 Past

  • 1MEDP shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 25.22%, which is quite impressive.
  • 1MEDP shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 33.22% yearly.
  • 1MEDP shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 13.88%.
  • 1MEDP shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 19.62% yearly.
EPS 1Y (TTM)25.22%
EPS 3Y37.96%
EPS 5Y33.22%
EPS Q2Q%28.24%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y22.68%
Revenue growth 5Y19.62%
Sales Q2Q%23.74%

3.2 Future

  • The Earnings Per Share is expected to grow by 12.31% on average over the next years. This is quite good.
  • 1MEDP is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.31% yearly.
EPS Next Y19.47%
EPS Next 2Y15.07%
EPS Next 3Y13.51%
EPS Next 5Y12.31%
Revenue Next Year19.22%
Revenue Next 2Y15.5%
Revenue Next 3Y13.43%
Revenue Next 5Y12.31%

3.3 Evolution

  • The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
1MEDP.MI Yearly Revenue VS Estimates1MEDP.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
1MEDP.MI Yearly EPS VS Estimates1MEDP.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

4

4. 1MEDP.MI Valuation Analysis

4.1 Price/Earnings Ratio

  • 1MEDP is valuated quite expensively with a Price/Earnings ratio of 30.74.
  • The rest of the industry has a similar Price/Earnings ratio as 1MEDP.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, 1MEDP is valued a bit more expensive.
  • With a Price/Forward Earnings ratio of 26.28, 1MEDP can be considered very expensive at the moment.
  • 1MEDP's Price/Forward Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 22.51, 1MEDP is valued at the same level.
Industry RankSector Rank
PE 30.74
Fwd PE 26.28
1MEDP.MI Price Earnings VS Forward Price Earnings1MEDP.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, 1MEDP is valued a bit more expensive than 77.27% of the companies in the same industry.
  • 1MEDP's Price/Free Cash Flow ratio is rather cheap when compared to the industry. 1MEDP is cheaper than 86.36% of the companies in the same industry.
Industry RankSector Rank
P/FCF 18.29
EV/EBITDA 22.58
1MEDP.MI Per share data1MEDP.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60

4.3 Compensation for Growth

  • The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • 1MEDP has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as 1MEDP's earnings are expected to grow with 13.51% in the coming years.
PEG (NY)1.58
PEG (5Y)0.93
EPS Next 2Y15.07%
EPS Next 3Y13.51%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. 1MEDP.MI Dividend Analysis

5.1 Amount

  • 1MEDP does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

1MEDP.MI Fundamentals: All Metrics, Ratios and Statistics

MEDPACE HOLDINGS INC

BIT:1MEDP (3/2/2026, 7:00:00 PM)

380.6

-143.2 (-27.34%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-09
Earnings (Next)04-20
Inst Owners84.9%
Inst Owner ChangeN/A
Ins Owners0.51%
Ins Owner ChangeN/A
Market Cap10.80B
Revenue(TTM)2.36B
Net Income(TTM)433.00M
Analysts70.53
Price Target426.96 (12.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)5.04%
Min EPS beat(2)2.57%
Max EPS beat(2)7.52%
EPS beat(4)4
Avg EPS beat(4)12.38%
Min EPS beat(4)2.57%
Max EPS beat(4)21.62%
EPS beat(8)8
Avg EPS beat(8)12.23%
EPS beat(12)11
Avg EPS beat(12)11.91%
EPS beat(16)15
Avg EPS beat(16)13.95%
Revenue beat(2)2
Avg Revenue beat(2)5.36%
Min Revenue beat(2)0.93%
Max Revenue beat(2)9.78%
Revenue beat(4)3
Avg Revenue beat(4)3.28%
Min Revenue beat(4)-1.63%
Max Revenue beat(4)9.78%
Revenue beat(8)3
Avg Revenue beat(8)0.43%
Revenue beat(12)7
Avg Revenue beat(12)1.26%
Revenue beat(16)9
Avg Revenue beat(16)1.1%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 30.74
Fwd PE 26.28
P/S 5.25
P/FCF 18.29
P/OCF 17.41
P/B 42.16
P/tB N/A
EV/EBITDA 22.58
EPS(TTM)12.38
EY3.25%
EPS(NY)14.48
Fwd EY3.81%
FCF(TTM)20.81
FCFY5.47%
OCF(TTM)21.87
OCFY5.74%
SpS72.5
BVpS9.03
TBVpS-12.37
PEG (NY)1.58
PEG (5Y)0.93
Graham Number50.15
Profitability
Industry RankSector Rank
ROA 24.7%
ROE 147.46%
ROCE 108.09%
ROIC 91.45%
ROICexc 233.48%
ROICexgc N/A
OM 21.5%
PM (TTM) 18.36%
GM 31.11%
FCFM 28.7%
ROA(3y)18.14%
ROA(5y)15.16%
ROE(3y)54.33%
ROE(5y)40%
ROIC(3y)38.75%
ROIC(5y)29.27%
ROICexc(3y)71.87%
ROICexc(5y)52.56%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)47.22%
ROCE(5y)35.45%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3Y64.05%
ROICexc growth 5Y48.31%
OM growth 3Y6.82%
OM growth 5Y7.46%
PM growth 3Y6.48%
PM growth 5Y10.5%
GM growth 3Y2.7%
GM growth 5Y1.75%
F-Score8
Asset Turnover1.35
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 120.93%
Cap/Sales 1.46%
Interest Coverage 250
Cash Conversion 132.81%
Profit Quality 156.3%
Current Ratio 0.57
Quick Ratio 0.57
Altman-Z 6.54
F-Score8
WACC11.01%
ROIC/WACC8.31
Cap/Depr(3y)142.96%
Cap/Depr(5y)144.54%
Cap/Sales(3y)2.07%
Cap/Sales(5y)2.41%
Profit Quality(3y)141.71%
Profit Quality(5y)142.32%
High Growth Momentum
Growth
EPS 1Y (TTM)25.22%
EPS 3Y37.96%
EPS 5Y33.22%
EPS Q2Q%28.24%
EPS Next Y19.47%
EPS Next 2Y15.07%
EPS Next 3Y13.51%
EPS Next 5Y12.31%
Revenue 1Y (TTM)13.88%
Revenue growth 3Y22.68%
Revenue growth 5Y19.62%
Sales Q2Q%23.74%
Revenue Next Year19.22%
Revenue Next 2Y15.5%
Revenue Next 3Y13.43%
Revenue Next 5Y12.31%
EBIT growth 1Y24.03%
EBIT growth 3Y31.04%
EBIT growth 5Y28.55%
EBIT Next Year22.27%
EBIT Next 3Y13.24%
EBIT Next 5Y14.69%
FCF growth 1Y79.18%
FCF growth 3Y34.54%
FCF growth 5Y25.47%
OCF growth 1Y71.92%
OCF growth 3Y32.23%
OCF growth 5Y24.7%

MEDPACE HOLDINGS INC / 1MEDP.MI Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MEDPACE HOLDINGS INC?

ChartMill assigns a fundamental rating of 7 / 10 to 1MEDP.MI.


Can you provide the valuation status for MEDPACE HOLDINGS INC?

ChartMill assigns a valuation rating of 4 / 10 to MEDPACE HOLDINGS INC (1MEDP.MI). This can be considered as Fairly Valued.


How profitable is MEDPACE HOLDINGS INC (1MEDP.MI) stock?

MEDPACE HOLDINGS INC (1MEDP.MI) has a profitability rating of 9 / 10.


What is the valuation of MEDPACE HOLDINGS INC based on its PE and PB ratios?

The Price/Earnings (PE) ratio for MEDPACE HOLDINGS INC (1MEDP.MI) is 30.74 and the Price/Book (PB) ratio is 42.16.


How financially healthy is MEDPACE HOLDINGS INC?

The financial health rating of MEDPACE HOLDINGS INC (1MEDP.MI) is 8 / 10.